This is a preview of subscription content, log in via an institution to check access.
Reference
Bansal M, et al. Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled Diabetes. Applied Health Economics and Health Policy : 23 Jun 2018. Available from: URL: https://doi.org/10.1007/s40258-018-0398-2
Rights and permissions
About this article
Cite this article
Reduction in HbA1c decreases diabetes-related costs. PharmacoEcon Outcomes News 806, 24 (2018). https://doi.org/10.1007/s40274-018-5067-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5067-z